Shows & conferences

There are no forthcoming events currently.

Follow us

Most popular News

1 Eli Lilly reports positive phase 3 results for a weekly insulin formulation

Webinars

Upcoming supplier webinars

17 Sep 2024 Tue Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS Mixed-Mode Chromatography Media Thermo Fisher Scientific - Biosciences

Headlines

Eli Lilly reports positive phase 3 results for a weekly insulin formulation
FDA lifts partial clinical hold on phase 3 low blood sugar treatment
How modern trial designs propel cancer therapies to the market - interview
Candid Therapeutics launches with $370m to tackle autoimmunity with T-cell engagers
Therapy for aggressive brain cancer receives FDA clearance to start phase 1
Neuromuscular diseases in crosshairs in Forge Biologics gene therapy collaboration
Lilly to collaborate with Haya Therapeutics to develop drugs for metabolic conditions
ArsenalBio bags $325 million to develop CRISPR-engineered cell therapies
European Commission grants orphan drug designation for rare disease gene therapy
Orgenesis touts early clinical promise of CAR-T therapy with decentralized production in mind
FDA grants expanded approval for Emergent Bio’s mpox vaccine